KPV Laboratory Grade — Australia
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports KPV (CAS: 122334-06-9) to research institutions in Australia. Our WHO-GMP certified facility in India supplies 98%+ purity KPV for anti-inflammatory melanocortin peptide research.
KPV Export Specifications for Australia
| Compound | KPV |
| CAS Number | 122334-06-9 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | TGA |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to Australia | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of KPV
KPV is used in anti-inflammatory melanocortin peptide research. Research institutions in Australia source this compound for preclinical studies under applicable TGA research regulations.
Why Australia Researchers Source KPV from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for TGA compliance
- Temperature-controlled DHL/FedEx shipping to Australia
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in Australia
Semaglutide in Australia | Tirzepatide in Australia | Retatrutide in Australia | Liraglutide in Australia
KPV — Other Countries
KPV in USA | KPV in UK | KPV in Germany | KPV in Canada
Source from India — Key Manufacturing Cities
KPV in Mumbai, India | KPV in Delhi, India | KPV in Hyderabad, India | KPV in Bangalore, India
Request KPV for your Australia research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
